Pangea Biomed

Proprietary platform offering response prediction for dozens of cancer types

placeTel Aviv, Tel Aviv, Israel calendar_todayFounded 2018 groups21 employees language pangeabiomed.com

Innovation

2 patent families — focus: Physics & computing; filing pace steady. Cited 14 times.

YearFilings
20232
20252

Investor mix

2 investors on record; lead investors include NFX.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon